Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov;29(11):2388-2390.
doi: 10.3201/eid2911.230837.

Case Report and Literature Review of Prosthetic Cardiovascular Mucormycosis

Review

Case Report and Literature Review of Prosthetic Cardiovascular Mucormycosis

Baptiste Hoellinger et al. Emerg Infect Dis. 2023 Nov.

Abstract

We report a rare case of aorto-bi-iliac prosthetic allograft mucormycosis in a 57-year-old immunocompetent patient in France. Outcome was favorable after surgery and dual antifungal therapy with liposomal amphotericin B and isavuconazole. In a literature review, we identified 12 other cases of prosthetic vascular or heart valve mucormycosis; mortality rate was 38%.

Keywords: Candida albicans; France; Hansmann Y; Lactobacillus plantarum; Letscher-Bru V; Magnus L; Mucorales; Ohana M; Rhizopus microsporus; Ruch Y; Suggested citation for this article: Hoellinger B; endocarditis; et al. Case report and literature review of prosthetic cardiovascular mucormycosis. Emerg Infect Dis. 2023 Nov [date cited]. https://doi.org/10.3201/eid2911.230837; fungal infection; fungi; mucormycosis; prosthetic vascular graft infection.

PubMed Disclaimer

Figures

Figure
Figure
Vascular prosthetic mucormycosis in a 57-year-old immunocompetent patient in France. A, B) Aortic computed-tomography angiogram (A) and 3-dimensional reconstruction (B) show the periprosthetic collection and vascular leak (arrows). C) Intraoperative view shows the graft exposure and false necrotic membranes.

References

    1. Danion F, Coste A, Le Hyaric C, Melenotte C, Lamoth F, Calandra T, et al. What is new in pulmonary mucormycosis? J Fungi (Basel). 2023;9:307. 10.3390/jof9030307 - DOI - PMC - PubMed
    1. Ben-Ami R, Luna M, Lewis RE, Walsh TJ, Kontoyiannis DP. A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. J Infect. 2009;59:134–8. 10.1016/j.jinf.2009.06.002 - DOI - PMC - PubMed
    1. Millon L, Larosa F, Lepiller Q, Legrand F, Rocchi S, Daguindau E, et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis. 2013;56:e95–101. 10.1093/cid/cit094 - DOI - PubMed
    1. Millaire A, Leroy O, Gaday V, de Groote P, Beuscart C, Goullard L, et al. Incidence and prognosis of embolic events and metastatic infections in infective endocarditis. Eur Heart J. 1997;18:677–84. 10.1093/oxfordjournals.eurheartj.a015315 - DOI - PubMed
    1. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23–34. 10.1093/cid/cir866 - DOI - PubMed

Substances